These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Resveratrol protects against a model of vacuous chewing movements induced by reserpine in mice. Busanello A; Barbosa NB; Peroza LR; Farias LE; Burger ME; Barreto KP; Fachinetto R Behav Pharmacol; 2011 Feb; 22(1):71-5. PubMed ID: 21127417 [TBL] [Abstract][Full Text] [Related]
6. Gallic acid decreases vacuous chewing movements induced by reserpine in rats. Reckziegel P; Peroza LR; Schaffer LF; Ferrari MC; de Freitas CM; Bürger ME; Fachinetto R Pharmacol Biochem Behav; 2013 Mar; 104():132-7. PubMed ID: 23313549 [TBL] [Abstract][Full Text] [Related]
7. Gabapentin reduces haloperidol-induced vacuous chewing movements in mice. Ceretta APC; de Freitas CM; Schaffer LF; Reinheimer JB; Dotto MM; de Moraes Reis E; Scussel R; Machado-de-Ávila RA; Fachinetto R Pharmacol Biochem Behav; 2018 Mar; 166():21-26. PubMed ID: 29374574 [TBL] [Abstract][Full Text] [Related]
8. Soung HS; Wang MH; Chang KC; Chen CN; Chang Y; Yang CC; Tseng HC Neurotox Res; 2018 Oct; 34(3):375-387. PubMed ID: 29629512 [TBL] [Abstract][Full Text] [Related]
9. Effects of age on reserpine-induced orofacial dyskinesia and possible protection of diphenyl diselenide. Burger M; Fachinetto R; Calegari L; Paixão MW; Braga AL; Rocha JB Brain Res Bull; 2004 Dec; 64(4):339-45. PubMed ID: 15561469 [TBL] [Abstract][Full Text] [Related]
10. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine. Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222 [TBL] [Abstract][Full Text] [Related]
11. Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors. Cunha AS; Matheus FC; Moretti M; Sampaio TB; Poli A; Santos DB; Colle D; Cunha MP; Blum-Silva CH; Sandjo LP; Reginatto FH; Rodrigues AL; Farina M; Prediger RD Behav Brain Res; 2016 Oct; 312():64-76. PubMed ID: 27306571 [TBL] [Abstract][Full Text] [Related]
12. Protective effect of nebivolol on reserpine-induced neurobehavioral and biochemical alterations in rats. Nade VS; Shendye NV; Kawale LA; Patil NR; Khatri ML Neurochem Int; 2013 Oct; 63(4):316-21. PubMed ID: 23871717 [TBL] [Abstract][Full Text] [Related]
13. Harpagophytum Procumbens Ethyl Acetate Fraction Reduces Fluphenazine-Induced Vacuous Chewing Movements and Oxidative Stress in Rat Brain. Schaffer LF; de Freitas CM; Chiapinotto Ceretta AP; Peroza LR; de Moraes Reis E; Krum BN; Busanello A; Boligon AA; Sudati JH; Fachinetto R; Wagner C Neurochem Res; 2016 May; 41(5):1170-84. PubMed ID: 26732278 [TBL] [Abstract][Full Text] [Related]
14. Effect of Hypericum perforatum on different models of movement disorders in rats. Reis EM; Röpke J; Busanello A; Reckziegel P; Leal CQ; Wagner C; Boligon AA; Athayde ML; Fachinetto R Behav Pharmacol; 2013 Oct; 24(7):623-7. PubMed ID: 23962987 [TBL] [Abstract][Full Text] [Related]
15. Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors. Raghavendra V; Naidu PS; Kulkarni SK Brain Res; 2001 Jun; 904(1):149-52. PubMed ID: 11516422 [TBL] [Abstract][Full Text] [Related]
16. Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin. Naidu PS; Singh A; Kulkarni SK Pharmacology; 2004 Feb; 70(2):59-67. PubMed ID: 14685008 [TBL] [Abstract][Full Text] [Related]
17. Reserpine does not induce orofacial dyskinesia in spontaneously hypertensive rats. Queiroz CM; Piovezan RD; Frussa-Filho R Eur J Pharmacol; 1998 Sep; 356(2-3):105-8. PubMed ID: 9774239 [TBL] [Abstract][Full Text] [Related]
18. Effects of baclofen on reserpine-induced vacuous chewing movements in mice. Castro JP; Frussa-Filho R; Fukushiro DF; Silva RH; Medrano WA; Ribeiro Rde A; Abílio VC Brain Res Bull; 2006 Feb; 68(6):436-41. PubMed ID: 16459199 [TBL] [Abstract][Full Text] [Related]
19. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Mithani S; Atmadja S; Baimbridge KG; Fibiger HC Psychopharmacology (Berl); 1987; 93(1):94-100. PubMed ID: 2888156 [TBL] [Abstract][Full Text] [Related]
20. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia. Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]